These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 heparin-binding (acidic and basic fibroblast) growth factor gene expression in human vascular smooth muscle cells. Winkles JA; Gay CG Cell Growth Differ; 1991 Nov; 2(11):531-40. PubMed ID: 1726053 [TBL] [Abstract][Full Text] [Related]
4. Heparin-binding growth factor-I (endothelial cell growth factor) binds to endothelium in vivo. Rosengart TK; Kupferschmid JP; Ferrans VJ; Casscells W; Maciag T; Clark RE J Vasc Surg; 1988 Feb; 7(2):311-7. PubMed ID: 2448501 [TBL] [Abstract][Full Text] [Related]
5. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952 [TBL] [Abstract][Full Text] [Related]
6. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels. Mioh H; Chen JK J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412 [TBL] [Abstract][Full Text] [Related]
7. Opposite effects of monokines (interleukin-1 and tumor necrosis factor) on proliferation and heparin-binding (fibroblast) growth factor binding to human aortic endothelial and smooth muscle cells. Sawada H; Kan M; McKeehan WL In Vitro Cell Dev Biol; 1990 Feb; 26(2):213-6. PubMed ID: 2312505 [TBL] [Abstract][Full Text] [Related]
8. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Winkles JA; Friesel R; Burgess WH; Howk R; Mehlman T; Weinstein R; Maciag T Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7124-8. PubMed ID: 2444975 [TBL] [Abstract][Full Text] [Related]
9. Internalization and degradation of heparin binding growth factor-I by endothelial cells. Friesel R; Maciag T Biochem Biophys Res Commun; 1988 Mar; 151(3):957-64. PubMed ID: 2451523 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat. Rosengart TK; Kuperschmid JP; Maciag T; Clark RE Circ Res; 1989 Feb; 64(2):227-34. PubMed ID: 2463884 [TBL] [Abstract][Full Text] [Related]
11. Heparin-binding (fibroblast) growth factors type one and two genes are co-expressed in proliferating normal human vascular endothelial and smooth muscle cells in culture. Mansson PE; Malark M; Sawada H; Kan M; McKeehan WL In Vitro Cell Dev Biol; 1990 Feb; 26(2):209-12. PubMed ID: 1690207 [TBL] [Abstract][Full Text] [Related]
12. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. Myoken Y; Kan M; Sato GH; McKeehan WL; Sato JD Exp Cell Res; 1990 Dec; 191(2):299-304. PubMed ID: 1701723 [TBL] [Abstract][Full Text] [Related]
13. Fibronectin, not laminin, mediates heparin-dependent heparin-binding growth factor type I binding to substrata and stimulation of endothelial cell growth. Kan M; Shi EG In Vitro Cell Dev Biol; 1990 Dec; 26(12):1151-6. PubMed ID: 1706698 [TBL] [Abstract][Full Text] [Related]
14. Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1: lack of correlation with growth factor binding. Belford DA; Hendry IA; Parish CR Biochemistry; 1992 Jul; 31(28):6498-503. PubMed ID: 1378755 [TBL] [Abstract][Full Text] [Related]
15. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. Rosengart TK; Johnson WV; Friesel R; Clark R; Maciag T Biochem Biophys Res Commun; 1988 Apr; 152(1):432-40. PubMed ID: 2451918 [TBL] [Abstract][Full Text] [Related]
16. High and low affinity binding of heparin-binding growth factor to a 130-kDa receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. Kan M; DiSorbo D; Hou JZ; Hoshi H; Mansson PE; McKeehan WL J Biol Chem; 1988 Aug; 263(23):11306-13. PubMed ID: 2457020 [TBL] [Abstract][Full Text] [Related]
17. Receptor phenotype underlies differential response of hepatocytes and nonparenchymal cells to heparin-binding fibroblast growth factor type 1 (aFGF) and type 2 (bFGF). Kan M; Yan GC; Xu J; Nakahara M; Hou J In Vitro Cell Dev Biol; 1992; 28A(7-8):515-20. PubMed ID: 1381709 [TBL] [Abstract][Full Text] [Related]
18. Heparin-binding growth factor type one and platelet-derived growth factor are required for the optimal expression of cell surface low density lipoprotein receptor binding activity in human adult arterial smooth muscle cells. Chen JK; Hoshi H; McKeehan WL In Vitro Cell Dev Biol; 1988 Mar; 24(3):199-204. PubMed ID: 2450862 [TBL] [Abstract][Full Text] [Related]
19. Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Kan M; Huang JS; Mansson PE; Yasumitsu H; Carr B; McKeehan WL Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7432-6. PubMed ID: 2477840 [TBL] [Abstract][Full Text] [Related]
20. Initial characterization of endothelial mitogens produced by bovine corpora lutea from the estrous cycle. Grazul-Bilska AT; Redmer DA; Killilea SD; Zheng J; Reynolds LP Biochem Cell Biol; 1993; 71(5-6):270-7. PubMed ID: 7506042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]